Whole Genome and Exome Sequencing Markets by Research, Clinical, Direct to Consumer, and AgriBio including Test Price and Volume Forecasts with Executive and Consultant Guides 2018 to 2022

  • ID: 4412925
  • Report
  • Region: Global
  • 319 Pages
  • Howe Sound Research
1 of 5
Whole Genome Sequencing costs plummet. Industry on verge of mainstream breakout into Healthcare, Consumer and Agricultural Markets. A new industry emerges.

FEATURED COMPANIES

  • 23andMe
  • Berry Genomics
  • Danaher
  • Genomic Health
  • Life Letters
  • Phosphorus
  • MORE

Will all newborns receive Whole Genome Sequencing at birth?  How fast will Direct to Consumer Testing grow?  What sequencing technology will take the lead? What’s holding the industry back?  Where are the over 800 locations that have high throughput devices?

Our facts and support = Your success.

A plummeting of costs for Whole Genome Sequencing is creating a gold rush for market players.  New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players are racing for market share on a truly global stage.  The report forecasts the market size out to 2022.  The report includes detailed breakouts for 14 countries and 5 regions.

Germline? Somatic? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon.  What are the issues?  Find the opportunities, and the pitfalls.  Understand growth expectations and the ultimate market forecasts for the next five years.

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report.  Your credit card order sends the report to your inbox instantly.  Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data. 

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 23andMe
  • Berry Genomics
  • Danaher
  • Genomic Health
  • Life Letters
  • Phosphorus
  • MORE

i.  Whole Genome Sequencing Market - Strategic Situation Analysis
ii.  Guide for Executives, Marketing, Sales and Business Development Staff
iii.  Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition
1.1 Whole Genome Sequencing Definition In This Report
1.1.1 Exome Sequencing
1.1.2 Direct to Consumer
1.1.3 Pathogens and Tumors
1.1.4 Germline and Somatic
1.2 The Genomics Revolution
1.3 Market Definition
1.3.1 Volumes
1.3.2 Prices
1.3.3 Revenue Market Size
1.4 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for laboratory testing
1.5 Sizing the Genome - Not What You Think
1.5.1 Cost, Price and Genome Size, Pricing Practice

2. Market Overview
2.1 Market Participants Play Different Roles
2.1.1 Instrument Manufacturer
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 DTC Lab
2.1.9 Sequencing Labs
2.1.10 Audit body
2.2 Whole Genome Sequencing -Markets, Examples and Discussion
2.2.1 Direct to Consumer - Two Approaches
2.2.1.1 The New Age of Medical Information
2.2.1.2 Dangers in  DTC-WGS - Health Costs and Regulation
2.2.1.3 Newborn and Prenatal - A Brave New World
2.2.1.4 DTC - How Many Segments?
2.2.2 Research Markets
2.2.2.1  Research Funding and Capital Expense
2.2.2.2  WGS Datasets Preferred
2.2.2.3  Existing research repurposed
2.2.2.4  Organism Wide Market
2.2.2.5  Service Suppliers Respond
2.2.3 Clinical - Understanding Germline and Somatic
2.2.3.1 Somatic - Chasing Mutations and Pharmacogenomics
2.2.4 Pathogen Testing
2.2.4.1 The Hepatitis C Story
2.2.4.2 Will the Microbiology Department Disappear?
2.2.5 AgriBio - Big Business
2.2.5.1 GMO is Here to Stay
2.2.5.2 WGS Benefits and Risks
2.2.5.3 The New Agriculture
2.3 Industry Structure
2.3.1 Hospital’s Testing Share
2.3.2 Economies of Scale
2.3.3 Instrument Manufacturer Role
2.3.4 Healthcare Industry Impacts - Still Struggling
2.3.4.1 Can the Healthcare Industry Adapt?
2.3.4.2 Genetic Counselling as an Industry
2.3.4.3 WGES Adoption and Cannibalization
2.3.4.4 The Meaning of Grail
2.4 Profiles of Key Companies
2.4.1 Roche Molecular Diagnostics
2.4.2 Illumina
2.4.3 Grail
2.4.4 Complete Genomics - BGI
2.4.5 Qiagen
2.4.6 GE Global Research
2.4.7 BGI Genomics Co. Ltd.
2.4.8 Oxford Nanopore Technologies
2.4.9 Genomic Health
2.4.10 Pacific Biosciences
2.4.11 Siemens Healthcare
2.4.12 23 and Me
2.4.13 Ancestry.com
2.4.14 Bio-Rad
2.4.15 Thermo Fisher
2.4.16 Fabric Genomics
2.4.17 Centogene
2.4.18 Gene by Gene Ltd
2.4.19 Veritas Genetics
2.4.20 Dante Labs
2.4.21 Guardiome
2.4.22 Sure Genomics
2.4.23 Novogene
2.4.24 Helix
2.4.25 Genomics Personalized Health (GPH)
2.4.26 Sequencing.com
2.4.27 Omega Bioservices
2.4.28 ORIG3N
2.4.29 Human Longevity, Inc.
2.4.30 Invitae

3. Market Trends
3.1 Factors Driving Growth
3.1.1 Diagnostic Factors
3.1.2 Interpreting the Code Otherwise.
3.1.3 Changes in Agriculture.
3.1.4 Fertility Technology Comes of Age
3.1.5 Pathogen Challenges
3.2 Factors Limiting Growth
3.2.1 Increased Competition Lowers Price
3.2.2 Lower Costs.
3.2.3 Healthcare Cost Concerns Curtail Growth.
3.2.4 Wellness has a downside
3.2.5 GMO Opposition Movement
3.3 Sequencing Instrumentation
3.3.1 Instrumentation Tenacity.
3.3.2 Declining Cost of Instruments Changes Industry Structure.
3.3.3 LISTING of CURRENT INSTRUMENT SPECIFICATIONS.
3.3.4 Long Reads - Further Segmentation.
3.3.5 Linked Reads.
3.3.6  New Sequencing Technologies

4. WGES Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
4.2 Future goal in UK is for every cancer patient to have his or her whole genome sequenced
4.3 Human Longevity Launches Whole Genome Product, MassMutual Partnerships
4.4 Influence of Whole Genome Sequencing growing
4.5 Rady Children's and Edico Genome Extend WGS Collaboration
4.6 $1500 to sequence newborns in China
4.7 Newborns to Get Whole Genome Sequencing
4.8 Eurofins Acquiring PerkinElmer’s NTD Laboratory Services Business
4.9 Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion
4.10 AstraZeneca taps gene pioneer Venter for huge drug-hunting sweep
4.11 The Cooper Companies’ Women’s Health Care Unit Acquires Genesis Genetics
4.12 Research Validates Preimplantation Genetic Diagnosis for Aneuploidy (PGD-A)
4.13 New Investments in Ancestry.com to Boost DNA Business
4.14 GHO Capital Announces Acquisition of DNA Diagnostics Center
4.15 PerkinElmer Launches Clinical Whole Genome Sequencing Services
4.16 WGS and AI help clinicians scale precision oncology
4.17  Veritas Genetics Buys Curoverse
4.18  Dante Labs Partners With Amazon UK for Special £349 Whole Genome Sequencing
4.19 Toolbox Genomics Launches Personalized Wellness App in Sequencing.com's Revolutionary App Market
4.20 CDC invests in WGS to help states respond to infectious disease threats
4.21 Factory contamination of medical device likely source of M. chimaera infection in patients in multiple countries
4.22 IBM Watson impresses in WGS brain tumour analysis
4.23  OneOme, Genome.One Partner to Offer Genetic Risk, PGx Service in Australia
4.24  WGS aids in Salmonella outbreak control
4.25 CombiMatrix In Merger Agreement with Invitae to be Acquired for $33 Million in Invitae Common Stock
4.53 Lifecode Receives CAP Accreditation, Discloses Funding
4.55 23andMe Gets FDA Clearance to Market Bloom Syndrome Carrier Test
4.60 Agena Bioscience Launches Smaller Format MassArray
4.62 The Journal of Molecular Diagnostics Publishes Special Article
4.71 BioReference Laboratories, Inc. Launches an Advanced Tumor Sequencing Program
4.76 New Aussie Firm Life Letters Launches Carrier, PGx Testing for Consumers
4.88 T2 Biosystems Inks $8.5M Lyme Disease Dx Deal with Canon US Life Sciences
4.89  Floragenex, Sedia Biosciences Merge
4.90 Myriad Genetics Signs Definitive Agreement to Acquire Assurex Health
4.91 Berry Genomics Seeks Public Listing in China Via Reverse Merger
4.92 Athletigen sees genetic testing as part of athletic training
4.93  AncestryDNA sees huge growth in demand for genetic testing
4.93 Phosphorus Raises $10 Million in Series A Funding to Build a Clinical Genomics Network . 233 
4.94 NeoGenomics Q1 Revenues Jump on Genetic Test Volume Growth
4.95 Nevada Population Health Study to Offer Free 23andMe Genetic Tests to Community
4.96 Danaher to buy Cepheid in $4 billion deal to expand in diagnostics

5.  Country Market Sizes - North America
5.1 United States of America
5.1.1 Research - Volumes, Prices, Revenues
5.1.2 Clinical - Volumes, Prices, Revenues
5.1.3 AgriBio - Volumes, Prices, Revenues
5.1.4 Direct to Consumer Testing - Volumes, Prices, Revenues
5.2 Canada
5.2.1 Research - Volumes, Prices, Revenues
5.2.2 Clinical  - Volumes, Prices, Revenues
5.2.3 AgriBio - Volumes, Prices, Revenues
5.2.4 Direct to Consumer Testing - Volumes, Prices, Revenues

6. Country Markets - Europe
6.1 France
6.1.1 Research - Volumes, Prices, Revenues
6.1.2 Clinical  - Volumes, Prices, Revenues
6.1.3 AgriBio - Volumes, Prices, Revenues
6.1.4 Direct to Consumer Testing - Volumes, Prices, Revenues
6.2 Germany
6.2.1 Research - Volumes, Prices, Revenues
6.2.2 Clinical  - Volumes, Prices, Revenues
6.2.3 AgriBio - Volumes, Prices, Revenues
6.2.4 Direct to Consumer Testing - Volumes, Prices, Revenues
6.3 United Kingdom
6.3.1 Research - Volumes, Prices, Revenues
6.3.2 Clinical  - Volumes, Prices, Revenues
6.3.3 AgriBio - Volumes, Prices, Revenues
6.3.4 Direct to Consumer Testing - Volumes, Prices, Revenues
6.4 Spain
6.4.1 Research - Volumes, Prices, Revenues
6.4.2 Clinical  - Volumes, Prices, Revenues
6.4.3 AgriBio - Volumes, Prices, Revenues
6.4.4 Direct to Consumer Testing - Volumes, Prices, Revenues
6.5 Italy
6.5.1 Research - Volumes, Prices, Revenues
6.5.2 Clinical  - Volumes, Prices, Revenues
6.5.3 AgriBio - Volumes, Prices, Revenues
6.5.4 Direct to Consumer Testing - Volumes, Prices, Revenues
6.6 Russia
6.6.1 Research - Volumes, Prices, Revenues
6.6.2 Clinical  - Volumes, Prices, Revenues
6.6.3 AgriBio Testing - Volumes, Prices, Revenues
6.6.4 Direct to Consumer Testing - Volumes, Prices, Revenues
6.7 Remainder of Europe and Former Soviet Union
6.7.1 Research - Volumes, Prices, Revenues
6.7.2 Clinical  - Volumes, Prices, Revenues
6.7.3 AgriBio - Volumes, Prices, Revenues
6.7.4 Direct to Consumer Testing - Volumes, Prices, Revenues

7. Country Markets - Asia Pacific
7.1 China
7.1.1 Research - Volumes, Prices, Revenues
7.1.2 Clinical  - Volumes, Prices, Revenues
7.1.3 AgriBio - Volumes, Prices, Revenues
7.1.4 Direct to Consumer Testing - Volumes, Prices, Revenues
7.2 Japan
7.2.1 Research - Volumes, Prices, Revenues
7.2.2 Clinical  - Volumes, Prices, Revenues
7.2.3 AgriBio - Volumes, Prices, Revenues
7.2.4 Direct to Consumer Testing - Volumes, Prices, Revenues
7.3 South Korea
7.3.1 Research - Volumes, Prices, Revenues
7.3.2 Clinical  - Volumes, Prices, Revenues
7.3.3 AgriBio - Volumes, Prices, Revenues
7.3.4 Direct to Consumer Testing - Volumes, Prices, Revenues
7.4 India
7.4.1 Research - Volumes, Prices, Revenues
7.4.2 Clinical  - Volumes, Prices, Revenues
5.1.3 AgriBio - Volumes, Prices, Revenues
7.4.4 Direct to Consumer Testing - Volumes, Prices, Revenues
7.5 Australia
7.5.1 Research - Volumes, Prices, Revenues
7.5.2 Clinical  - Volumes, Prices, Revenues
7.5.3 AgriBio  - Volumes, Prices, Revenues
7.5.4 Direct to Consumer Testing - Volumes, Prices, Revenues
7.6 Rest of Asia Pacific
7.6.1 Research - Volumes, Prices, Revenues
7.6.2 Clinical  - Volumes, Prices, Revenues
7.6.3 AgriBio- Volumes, Prices, Revenues
7.6.4 Direct to Consumer Testing - Volumes, Prices, Revenues

8. Country Markets - Latin America, Africa & The Middle East
8.1 Brazil
8.1.1 Research - Volumes, Prices, Revenues
8.1.2 Clinical  - Volumes, Prices, Revenues
8.1.3 AgriBio- Volumes, Prices, Revenues
8.1.4 Direct to Consumer Testing - Volumes, Prices, Revenues
8.2 Mexico
8.2.1 Research - Volumes, Prices, Revenues
8.2.2 Clinical  - Volumes, Prices, Revenues
8.2.3 AgriBio - Volumes, Prices, Revenues
8.2.4 Direct to Consumer Testing - Volumes, Prices, Revenues
8.3 Rest of Latin America
8.3.1 Research - Volumes, Prices, Revenues
8.3.2 Clinical  - Volumes, Prices, Revenues
8.3.3 AgriBio - Volumes, Prices, Revenues
8.3.4 Direct to Consumer Testing - Volumes, Prices, Revenues
8.4 Africa & The Middle East
8.4.1 Research - Volumes, Prices, Revenues
8.4.2 Clinical  - Volumes, Prices, Revenues
8.4.3 AgriBio- Volumes, Prices, Revenues
8.4.4 Direct to Consumer Testing - Volumes, Prices, Revenues

9. Global Market Summary
9.1 Global Market
9.1.1 Research - Volumes, Prices, Revenues
9.1.2 Clinical  - Volumes, Prices, Revenues
9.1.3 AgriBio - Volumes, Prices, Revenues
9.1.4 Direct to Consumer Testing - Volumes, Prices, Revenues

10. Vision of the Future of Whole Genome Sequencing

Appendices
I. United States Medicare System: January 2016 laboratory Fees Schedule - National Limit and Midpoint
II Methodology
II.1 Authors
II.2 Sources

List of Tables
Table 1 - The Base Pairs
Table 2 Most Common Traditional Genetic Disorders
Table 3 Medicare Clinical Lab Expenditures Actual & Forecast 2004 to 2020 ($Billion)
Table 4 List of GLOBAL SEQUENCING LOCATIONS
Table 5  Market Players by Type
Table 6 The Different Markets for Whole Genome Sequencing
Table 7 DTC Sub Segments
Table 8  Roles of WGS in AgriBio
Table 9 The Factors Driving Growth
Table 10 Factors Limiting Growth
Table 11 - Listing of Current Instrument Specifications
Table 12 Six New Sequencing Technologies
Table 13 USA Research - Volume Price and Revenue Forecast
Table 14 USA Clinical - Volume Price and Revenue Forecast
Table 15 USA AgriBio - Volume Price and Revenue Forecast
Table 16 USA Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 17 Canada Research - Volume Price and Revenue Forecast
Table 18 Canada Clinical  - Volume Price and Revenue Forecast
Table 19 Canada AgriBio - Volume Price and Revenue Forecast
Table 20 Canada Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 21 France Research - Volume Price and  Revenue Forecast
Table 22 France Clinical  - Volume Price and Revenue Forecast
Table 23 France AgriBio - Volume Price and Revenue Forecast
Table 24 France Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 25 Germany Research - Volume Price and  Revenue Forecast
Table 26 Germany Clinical  - Volume Price and Revenue Forecast
Table 27 Germany AgriBio - Volume Price and  Revenue Forecast
Table 28 Germany Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 29 U.K. Research - Volume Price and Revenue Forecast
Table 30 U.K. Clinical  - Volume Price and Revenue Forecast
Table 31 U.K. AgriBio - Volume Price and Revenue Forecast
Table 32 U.K. Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 33 Spain Research - Volume Price and Revenue Forecast
Table 34 Spain Clinical  - Volume Price and Revenue Forecast
Table 35 Spain AgriBio - Volume Price and Revenue Forecast
Table 36 Spain Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 37 Italy Research - Volume Price and  Revenue Forecast
Table 38 Italy Clinical  - Volume Price and Revenue Forecast
Table 39 Italy AgriBio - Volume Price and  Revenue Forecast
Table 40 Italy Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 41 Russia Research - Volume Price and Revenue Forecast
Table 42 Russia Clinical  - Volume Price and Revenue Forecast
Table 43 Russia AgriBio - Volume Price and Revenue Forecast
Table 44 Russia Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 45 Rest of Europe Research - Volume Price and Revenue Forecast
Table 46 Rest of Europe Clinical  - Volume Price and Revenue Forecast
Table 47 Rest of Europe AgriBio - Volume Price and Revenue Forecast
Table 48 Rest of Europe Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 49 China Research - Volume Price and Revenue Forecast
Table 50 China Clinical  - Volume Price and Revenue Forecast
Table 51 China AgriBio - Volume Price and Revenue Forecast
Table 52 China Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 53 Japan Research - Volume Price and Revenue Forecast
Table 54 Japan Clinical  - Volume Price and Revenue Forecast
Table 55 Japan AgriBio - Volume Price and Revenue Forecast
Table 56 Japan Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 57 South Korea Research - Volume Price and  Revenue Forecast
Table 58 South Korea Clinical  - Volume Price and Revenue Forecast
Table 59 South Korea AgriBio - Volume Price and  Revenue Forecast
Table 60 South Korea Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 61 India Research - Volume Price and  Revenue Forecast
Table 62 India Clinical  - Volume Price and Revenue Forecast
Table 63 India AgriBio - Volume Price and  Revenue Forecast
Table 64 India Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 65 Australia Research - Volume Price and  Revenue Forecast
Table 66 Australia Predictive Testing - Volume Price and Revenue Forecast
Table 67 Australia AgriBio - Volume Price and  Revenue Forecast
Table 68 Australia Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 69 Rest of Asia Pacific Research - Volume Price and  Revenue Forecast
Table 70 Rest of Asia Pacific Clinical  - Volume Price and Revenue Forecast
Table 71 Rest of Asia Pacific AgriBio- Volume Price and Revenue Forecast
Table 72 Rest of Asia Pacific Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 73 Brazil Research - Volume Price and Revenue Forecast
Table 74 Brazil Clinical  - Volume Price and Revenue Forecast
Table 75 Brazil AgriBio- Volume Price and Revenue Forecast
Table 76 Brazil Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 77 Mexico Research - Volume Price and  Revenue Forecast
Table 78 Mexico Clinical  - Volume Price and Revenue Forecast
Table 79 Mexico AgriBio - Volume Price and  Revenue Forecast
Table 80 Mexico Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 81 Rest of Latin America Research - Volume Price and Revenue Forecast
Table 82 Rest of Latin America Clinical  - Volume Price and Revenue Forecast
Table 83 Rest of Latin America AgriBio- Volume Price and  Revenue Forecast
Table 84 Rest of Latin America Direct to Consumer Testing - Volume Price and Revenue Forecast .
Table 85 Africa & Middle East Research - Volume Price and Revenue Forecast
Table 86 Africa & Middle East Clinical  - Volume Price and Revenue Forecast
Table 87 Africa & Middle East AgriBio- Volume Price and Revenue Forecast
Table 88 Africa & Middle East Direct to Consumer Testing - Volume Price and Revenue Forecast .
Table 89 Global Research - Volume Price and Revenue Forecast
Table 90 Global Clinical  - Volume Price and Revenue Forecast
Table 91 Global AgriBio - Volume Price and Revenue Forecast
Table 92 Global Direct to Consumer Testing - Volume Price and Revenue Forecast
Table 93 2016 Clinical Lab Fee Schedule

List of Figures
Figure 1 Medicare Clinical Lab Expenditures 2004 to 2020 ($Million)
Figure 2 Size of Genome for Various Species
Figure 3 Cost To Sequence a Human Genome

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 23andMe
  • Agena Bioscience
  • AI
  • Amazon UK
  • Ambry Genetics
  • Ancestry.com
  • AncestryDNA
  • Assurex Health
  • AstraZeneca
  • Athletigen
  • Berry Genomics
  • BGI Genomics Co. Ltd.
  • Bio-Rad
  • BioReference Laboratories, Inc.
  • Canon US Life Sciences
  • CDC
  • Centogene
  • Cepheid
  • CombiMatrix
  • Complete Genomics - BGI
  • Curoverse
  • Danaher
  • Dante Labs
  • DNA Diagnostics Center
  • Edico Genome
  • Eurofins
  • Fabric Genomics
  • Floragenex
  • GE Global Research
  • Gene by Gene Ltd
  • Genome.One
  • Genomic Health
  • Genomics Personalized Health (GPH)
  • GHO Capital
  • Grail
  • Guardiome
  • Helix
  • Human Longevity, Inc.
  • IBM Watson
  • Illumina
  • Invitae
  • Konica Minolta
  • Life Letters
  • Lifecode
  • Myriad Genetics
  • NeoGenomics
  • Novogene
  • Omega Bioservices
  • OneOme
  • ORIG3N
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • PerkinElmer
  • Phosphorus
  • Qiagen
  • Rady Children's
  • Roche Molecular Diagnostics
  • Sedia Biosciences
  • Sequencing.com
  • Siemens Healthcare
  • Sure Genomics
  • T2 Biosystems
  • The Cooper Companies’
  • Thermo Fisher
  • Toolbox Genomics
  • Veritas Genetics
  • WGS
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll